| Title |
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
|
|---|---|
| Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2017
|
| DOI | 10.2147/dmso.s129797 |
| Pubmed ID | |
| Authors |
Victoria L Fisher, Abd A Tahrani |
| Abstract |
Cardiac autonomic neuropathy (CAN) is a common and often-underdiagnosed complication of diabetes mellitus (DM). CAN is associated with increased mortality, cardiovascular disease, chronic kidney disease, and morbidity in patients with DM, but despite these significant consequences CAN often remains undiagnosed for a prolonged period. This is commonly due to the disease being asymptomatic until the later stages, as well as a lack of easily available screening strategies. In this article, we review the latest developments in the epidemiology, pathogenesis, diagnosis, consequences, and treatments of CAN in patients with DM. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 36% |
| Denmark | 1 | 9% |
| United States | 1 | 9% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Scientists | 3 | 27% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 174 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 12% |
| Student > Ph. D. Student | 19 | 11% |
| Student > Master | 16 | 9% |
| Researcher | 14 | 8% |
| Student > Postgraduate | 13 | 7% |
| Other | 36 | 21% |
| Unknown | 55 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 34% |
| Nursing and Health Professions | 10 | 6% |
| Engineering | 8 | 5% |
| Psychology | 6 | 3% |
| Sports and Recreations | 5 | 3% |
| Other | 26 | 15% |
| Unknown | 60 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2019.
All research outputs
#5,142,884
of 25,461,852 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#230
of 1,184 outputs
Outputs of similar age
#82,781
of 331,480 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#5
of 9 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.